Spravato, major depressive disorder

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...
The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...